Amylin Adventure
This educational resource is provided by Vindico Medical Education and supported by an educational grant from Novo Nordisk, Inc.
Disclaimer: This educational content is intended for educational purposes only. It has been developed using a combination of peer-reviewed references, insights from OpenEvidence, and expert opinion from 2 independent faculty members. The information presented is current as of June 2025. While every effort has been made to ensure accuracy, ongoing research and clinical developments may influence future recommendations. Healthcare professionals should exercise their own clinical judgment when applying the information in practice.
The Amylin Adventure is designed to equip healthcare professionals with cutting-edge knowledge of amylin biology and its therapeutic implications. The 4 hormones—amylin, glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon—interact in complex ways to regulate weight and affect obesity through their actions on the brain, stomach, adipose tissue, pancreas, bone, and liver.
This educational resource will explore amylin as well as these other 3 hormones and showcase their various actions throughout the body.
Amylin is a 37-amino-acid peptide hormone co-secreted with insulin by pancreatic beta-cells in response to a meal. Though it has a short half-life, amylin may play a significant role in metabolic regulation.
There are at least 3 amylin receptors, AMY1, AMY2 and AMY3, each of which is composed of the calcitonin receptor bound to one of three corresponding receptor activity-modifying proteins. Amylin receptors are considered proven drug targets and amylin mimetics are emerging as novel treatments for overweight, obesity and diabetes mellitus.
This continuing education activity is provided by 
This activity is supported by an educational grant from Novo Nordisk, Inc.
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
These activities are approved for AMA PRA Category 1 Credit(s)™.
About
Contact Us
For General inquiries, contact:
[email protected]
For Technical questions, contact:
[email protected]
For CME questions, contact:
[email protected]
Vindico Medical Education
6900 Grove Road
Building 100
Thorofare, NJ 08086-9447 USA
888-960-0256; 856-994-9400
FAX: 856-384-6680
Vindico Medical Education, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team through November 30, 2026.
Legal